What is the current Blood Analyser market size?

The Blood Analyser market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Blood Analyser market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Blood Analyser market?

Increasing demand for point-of-care testing drives the Blood Analyser market.

What are the major challenges facing the Blood Analyser market?

High costs and limited accessibility in developing regions challenge the market.

Which regions are leading the Blood Analyser market?

North America and Europe are the leading regions in the Blood Analyser market.

Who are the top companies in the Blood Analyser market?

Top companies include Roche, Abbott, and Siemens, dominating the market.

What future opportunities exist in the Blood Analyser market?

Emerging economies and technological advancements offer future outlook opportunities.

How does technology impact the Blood Analyser market?

Advances in technology improve test accuracy and efficiency in the Blood Analyser market.

What is the current regulatory landscape for the Blood Analyser market?

Stringent regulations and standards govern the Blood Analyser market, ensuring safety.

Which Companies Lead the Blood Analyser Market in 2026?

Blood Analyser by Application (Hospital, Laboratory), by Types (Automatic, Semiautomatic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Blood Analyser Market Overview

The Blood Analyser market refers to the industry that provides devices and equipment for analysing blood samples to diagnose and monitor various health conditions. As a crucial component of the healthcare sector, the Blood Analyser market size is estimated to be around $13.4 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $24.5 billion by 2033, driven by the increasing demand for industry expansion and advancements in technology. The scope of this market encompasses various types of blood analysers, including haematology analysers, clinical chemistry analysers, and molecular diagnostics.

Loading chart…

The Blood Analyser market is expected to grow at a CAGR of 8.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of chronic diseases, rising demand for point-of-care testing, and advancements in artificial intelligence and machine learning. Key forces shaping the industry include technology shifts towards automation and miniaturization, regulations such as the European Union's In Vitro Diagnostic Regulation, and consumer behavior trends towards personalized medicine. The largest region in the Blood Analyser market is North America, while the fastest-growing region is Asia-Pacific. These trends and drivers will continue to shape the industry, making it an exciting space for strategic planners and business development teams to explore.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	12.87 million
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sysmex Corporation; Danaher; Abbott; Siemens Healthineers; HORIBA Medical; Stratec SE (Diatron); Boule Diagnostics; Bio-Rad Laboratories; Nihon Kohden; Mindray; DyMind; Urit Medical; Rayto
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Analyser market is poised for significant growth, driven by various factors. The market dynamics are shaped by a combination of growth drivers, restraints, opportunities, and challenges that impact the overall Blood Analyser market size and growth forecast.

Growth Drivers2 items

Advances in technology, such as the development of point-of-care blood analysers, are increasing the accuracy and speed of blood tests, driving adoption and contributing to the growth of the Blood Analyser market.

The rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, is fueling the demand for blood tests, thereby driving the growth of the Blood Analyser market size.

Restraints2 items

The high cost of blood analysers, particularly advanced models, is a significant restraint on the growth of the Blood Analyser market, as it limits adoption in resource-constrained settings.

The lack of standardization in blood testing protocols and procedures is hindering the growth of the Blood Analyser market, as it creates interoperability issues and limits the comparability of test results.

Opportunities2 items

The increasing demand for portable and handheld blood analysers is creating new opportunities for market players to develop innovative, user-friendly products that can be used in a variety of settings.

The growing trend of personalized medicine is driving the demand for advanced blood analysers that can provide detailed, actionable insights into an individual's health, thereby creating opportunities for market growth.

Challenges2 items

The Blood Analyser market is subject to stringent regulations and standards, which can create challenges for market players, particularly new entrants, as they navigate complex compliance requirements.

The increasing competition in the Blood Analyser market is driving down prices and profit margins, making it challenging for market players to maintain their market share and achieve sustainable growth.

Market Segmentation

Loading chart…

The Blood Analyser market can be segmented based on Application. This segmentation category contributes to the overall Blood Analyser market size by highlighting the various uses of blood analysers in different medical fields. The main applications of blood analysers include clinical diagnostics, research and development, and blood banking. Understanding the Blood Analyser segmentation by application is crucial for market players to identify areas of growth and development. The application segment is a key aspect of market taxonomy, providing insights into the diverse uses of blood analysers.

The Types of blood analysers is another crucial segmentation category. This category includes subtypes such as fully automated analysers, semi-automated analysers, and point-of-care analysers. Each subtype has its own set of features, advantages, and limitations, contributing to the overall Blood Analyser market size. The types of blood analysers are an essential part of Blood Analyser segmentation, as they cater to different needs and requirements of medical professionals and researchers. By understanding the types of blood analysers, market players can develop targeted strategies to enhance their market presence.

Blood Analyser Segmentation Breakdown6 items

Application

Hospital

Laboratory

Types

Automatic

Semiautomatic

Regional Insights

Loading chart…

The Blood Analyser market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 35% of the global market, driven by increasing adoption of advanced diagnostic technologies, government policies supporting healthcare infrastructure development, and significant investments in research and development. North America follows, with a notable share, fueled by a mature ecosystem, high demographics awareness, and robust infrastructure.

The fastest-growing region is expected to be Asia Pacific, with key drivers including rising demographics and infrastructure development, growing adoption of point-of-care diagnostics, and increasing investments in digital healthcare. Latin America and Middle East & Africa are also poised for growth, driven by expanding healthcare access, improving policies, and growing ecosystem maturity. In contrast, Europe and North America will experience more modest growth due to market saturation and intense competition.

Regional Drivers5 items

Asia Pacific: increasing adoption, government policies, and significant investments

North America: mature ecosystem, high demographics awareness, and robust infrastructure

Europe: growing demand for point-of-care diagnostics and digital health solutions

Latin America: expanding healthcare access and improving policies

Middle East & Africa: growing ecosystem maturity and increasing investments in healthcare

Competitive Landscape

The Blood Analyser market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Blood Analyser competitive landscape is driven by key players that leverage these levers to maintain their market position. Global players tend to dominate the market, but local companies still have a significant presence, particularly in emerging economies.

Companies in the Blood Analyser market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have notable strategies:

Sysmex Corporation: regional expansion

Danaher: vertical integration

Abbott: premium pricing

Siemens Healthineers: innovation pipeline

HORIBA Medical: local manufacturing

Stratec SE: OEM tie-ups

Key Blood Analyser Companies13 items

Sysmex Corporation

Danaher

Abbott

Siemens Healthineers

HORIBA Medical

Stratec SE (Diatron)

Boule Diagnostics

Bio-Rad Laboratories

Nihon Kohden

Mindray

DyMind

Urit Medical

Rayto

Market Ecosystem

The Blood Analyser ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of blood analysers, as well as the provision of related services and support. Understanding the Blood Analyser ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and produce blood analysers

Technology providers — develop underlying technologies

System integrators / EPCs — integrate analysers into larger systems

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

Control points in the Blood Analyser ecosystem are largely influenced by regulators, standards bodies, and end users, who drive adoption and dictate requirements. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability and affordability of blood analysers. Switching costs and partnerships can also affect the ecosystem, particularly in terms of interoperability requirements. Furthermore, regional differences in the ecosystem can lead to variations in the availability and accessibility of blood analysers, highlighting the need for a nuanced understanding of the Blood Analyser ecosystem.

Recent Industry Insights

The Blood Analyser industry has witnessed significant developments over the last 12-18 months, shaping the Blood Analyser industry trends. Notable partnerships have been formed, such as collaborations between leading manufacturers and research institutions, to improve the accuracy and efficiency of blood analysis. Furthermore, the industry has seen a surge in mergers and acquisitions, with major players expanding their portfolios and strengthening their market presence.

Recent product launches have also contributed to the evolution of the Blood Analyser industry, with a focus on advanced technologies and point-of-care testing solutions. Additionally, regulatory changes have been implemented to ensure the safety and efficacy of blood analysis devices, while funding rounds and expansions have enabled companies to invest in research and development, driving innovation and growth in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Blood Analyser market. The market attractiveness is high due to the increasing demand for diagnostic tests and the growing prevalence of chronic diseases. The competitive intensity is moderate, with key players competing based on product innovation and pricing strategies. The long-term outlook for the Blood Analyser market outlook is positive, driven by advancements in technology and the rising need for point-of-care testing.

The innovation landscape is dynamic, with a focus on developing portable and user-friendly devices. The demand-supply balance is stable, with manufacturers addressing the growing demand for blood analysers. However, key risk factors include regulatory changes and technological disruptions. Overall, the Blood Analyser market is expected to experience steady growth, driven by the increasing adoption of diagnostic tests and the expanding applications of blood analysers.

11 items

1. Executive Summary

2. Blood Analyser Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Analyser Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Blood Analyser Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Laboratory

6.2. Global Blood Analyser Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Automatic

6.2.2. Semiautomatic

6.3. Global Blood Analyser Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Blood Analyser Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Analyser Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Analyser Market Competition by Key Manufacturers

8.1. Global Blood Analyser Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Blood Analyser: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Sysmex Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Danaher

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Siemens Healthineers

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. HORIBA Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Stratec SE (Diatron)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Boule Diagnostics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bio-Rad Laboratories

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Nihon Kohden

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Mindray

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. DyMind

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Urit Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Rayto

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Analyser Market

Figure 4: Global Blood Analyser Market: Drivers

Figure 5: Global Blood Analyser Market: Challenges

Figure 6: Global Blood Analyser Market: Trends

Figure 7: Global Blood Analyser Market: Opportunity

Figure 8: Global Blood Analyser Market: Restraint

Figure 9: Global Blood Analyser Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Blood Analyser Market Value (USD Million) By Region

Figure 15: Global Blood Analyser Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Blood Analyser Market Value (USD Million) By Region

Figure 23: Global Blood Analyser Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Analyser Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Analyser Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Analyser Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Blood Analyser Market Value (USD Million) By Region

Table 10: Global Blood Analyser Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Blood Analyser Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Blood Analyser Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Blood Analyser Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Sysmex Corporation Basic Information And Sales Area

Table 31: Sysmex Corporation. Products Portfolio

Table 32: Danaher Basic Information And Sales Area

Table 33: Danaher. Products Portfolio

Table 34: Abbott Basic Information And Sales Area

Table 35: Abbott. Products Portfolio

Table 36: Siemens Healthineers Basic Information And Sales Area

Table 37: Siemens Healthineers. Products Portfolio

Table 38: HORIBA Medical Basic Information And Sales Area

Table 39: HORIBA Medical. Products Portfolio

Table 40: Stratec SE (Diatron) Basic Information And Sales Area

Table 41: Stratec SE (Diatron). Products Portfolio

Table 42: Boule Diagnostics Basic Information And Sales Area

Table 43: Boule Diagnostics. Products Portfolio

Table 44: Bio-Rad Laboratories Basic Information And Sales Area

Table 45: Bio-Rad Laboratories. Products Portfolio

Table 46: Nihon Kohden Basic Information And Sales Area

Table 47: Nihon Kohden. Products Portfolio

Table 48: Mindray Basic Information And Sales Area

Table 49: Mindray. Products Portfolio

Table 50: DyMind Basic Information And Sales Area

Table 51: DyMind. Products Portfolio

Table 52: Urit Medical Basic Information And Sales Area

Table 53: Urit Medical. Products Portfolio

Table 54: Rayto Basic Information And Sales Area

Table 55: Rayto. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Blood Analyser Market Value (USD Million) By Region

Table 61: Global Blood Analyser Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Blood Analyser Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	12.87 million
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sysmex Corporation; Danaher; Abbott; Siemens Healthineers; HORIBA Medical; Stratec SE (Diatron); Boule Diagnostics; Bio-Rad Laboratories; Nihon Kohden; Mindray; DyMind; Urit Medical; Rayto
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, is fueling the demand for blood tests, thereby driving the growth of the Blood Analyser market size.

Restraints2 items

The high cost of blood analysers, particularly advanced models, is a significant restraint on the growth of the Blood Analyser market, as it limits adoption in resource-constrained settings.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Blood Analyser Segmentation Breakdown6 items

Application

Hospital

Laboratory

Types

Automatic

Semiautomatic

Regional Insights

Loading chart…

Regional Drivers5 items

Asia Pacific: increasing adoption, government policies, and significant investments

North America: mature ecosystem, high demographics awareness, and robust infrastructure

Europe: growing demand for point-of-care diagnostics and digital health solutions

Latin America: expanding healthcare access and improving policies

Middle East & Africa: growing ecosystem maturity and increasing investments in healthcare

Competitive Landscape

Sysmex Corporation: regional expansion

Danaher: vertical integration

Abbott: premium pricing

Siemens Healthineers: innovation pipeline

HORIBA Medical: local manufacturing

Stratec SE: OEM tie-ups

Key Blood Analyser Companies13 items

Sysmex Corporation

Danaher

Abbott

Siemens Healthineers

HORIBA Medical

Stratec SE (Diatron)

Boule Diagnostics

Bio-Rad Laboratories

Nihon Kohden

Mindray

DyMind

Urit Medical

Rayto

Market Ecosystem

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and produce blood analysers

Technology providers — develop underlying technologies

System integrators / EPCs — integrate analysers into larger systems

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

Recent Industry Insights

Analyst Overview

Table of Contents